J Jervell

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

Anthony Barnett, Stephen C. Bain, Paul Bouter et al. · New England Journal of Medicine · 2004 · 916 citations · Full text

Medicine, Nephrology, Pharmacology +12

Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy

Andrew J.M. Boulton, F. A. Gries, J Jervell · Diabetic Medicine · 1998 · 356 citations

Medicine, Internal Medicine, Neurology +13

Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.

Jørgen Vildershøj Bjørnholt, Gunnar Erikssen, E. Aaser et al. · Diabetes Care · 1999 · 205 citations

Medicine, Endocrinology, Diabetology +12

Sandostatin LAR in Acromegalic Patients: Long Term Treatment

A K Fløgstad, Johan Halse, S. J. Bakke et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 177 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Sandostatin® LAR®: A promising therapeutic tool in the management of acromegalic patients

Ioana Lancranjan, Christian Bruns, P Jaquet et al. · Metabolism · 1996 · 148 citations

Medicine, Endocrinology, Pharmacology +6